Study demonstrated that enriched genes including IL1B [799], CXCR1 [800], FFAR4 [801], VIP (vasoactive intestinal peptide) [802], and GATA3 [803] have been identified as a key candidate genes in patients with gastroesophageal reflux disease. This evidence concerns the gene VIP and gastroesophageal reflux disease.